You are here

Article info

Article menu
Case report
Immune microenvironment of basal cell carcinoma and tumor regression following combined PD-1/LAG-3 blockade

Authors

  • Julie Stein Deutsch Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Jonathan Lai Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Kara M Schenk Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Abha Soni Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Elizabeth M Will Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Logan L Engle Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Haiying Xu Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Alexandra Ogurtsova Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Vrinda Madan Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Jennifer K Chong Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Daphne Wang Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Benjamin F Green Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Peter Nguyen Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Megan D Schollenberger Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Evan J Lipson Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA The Mark Foundation Center for Advanced Genomics and Imaging, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Janis M Taube Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA The Mark Foundation Center for Advanced Genomics and Imaging, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles

Citation

Deutsch JS, Lai J, Schenk KM, et al
Immune microenvironment of basal cell carcinoma and tumor regression following combined PD-1/LAG-3 blockade
Journal for ImmunoTherapy of Cancer 2023;11:e007463. doi: 10.1136/jitc-2023-007463
Online issue publication 
December 14, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.